{
  "url": "https://struct.news/briefs/lyondellbasell-leans-on-licensing-and-catalysts-as-core-margin-goes-negative",
  "title": "Propylene oxide margins turned LyondellBasell’s quarter into a $1.5B profit surge",
  "summary": "Revenue climbed to $9.2B and operating margin jumped to 16.8%, mostly because higher prices from industry supply constraints and product-specific tightness widened spreads.",
  "published_at": "2026-07-31T16:19:04.181782+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": null,
    "ticker": "LYB",
    "cik": "1489393",
    "sector": null,
    "industry": null
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-07-31",
    "accession": "0001489393-26-000061",
    "url": "https://www.sec.gov/Archives/edgar/data/1489393/000148939326000061/lyb-20260630.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-01",
    "url": "https://www.sec.gov/Archives/edgar/data/1489393/000148939325000041/lyb-20250630.htm"
  },
  "reported_figures": [
    {
      "group": "Operating margin trend",
      "label": "Operating margin trend",
      "value": null,
      "display": "-1.4%",
      "unit": "percent",
      "period": "2018-12-31–2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001489393-26-000061",
        "filing_date": "2026-07-31"
      }
    }
  ],
  "watch_next": [
    {
      "type": "pricing",
      "statement": "Company attributes large revenue and margin increase to higher average selling prices driven by industry-wide supply constraints tied to the conflict in the Middle East.",
      "importance": "medium",
      "evidence": "\"This increase was primarily driven by higher average sales prices across many products, which reflected industry-wide supply constraints stemming from the conflict in the Middle East and contributed to higher revenues by 33%.\"",
      "source_date": "2026-07-31"
    },
    {
      "type": "demand",
      "statement": "Higher demand for catalysts and timing of higher-value licensing milestones materially increased EBITDA contribution in the quarter.",
      "importance": "medium",
      "evidence": "\"Second quarter of 2026 versus first quarter of 2026—Higher demand for catalysts accounted for approximately half of the increase in EBITDA, while the remaining increase was driven by higher licensing results as a greater number of higher-value contracts reached significant milestones.\"",
      "source_date": "2026-07-31"
    }
  ],
  "related_tickers": [
    "LYB"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}